KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Emergent BioSolutions (EBS) Receivables - Net (2016 - 2026)

Emergent BioSolutions has reported Receivables - Net over the past 17 years, most recently at $121.6 million for Q1 2026.

  • For Q1 2026, Receivables - Net fell 30.11% year-over-year to $121.6 million; the TTM value through Mar 2026 reached $121.6 million, down 30.11%, while the annual FY2025 figure was $84.2 million, 45.5% down from the prior year.
  • Receivables - Net for Q1 2026 was $121.6 million at Emergent BioSolutions, up from $84.2 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $290.1 million in Q2 2023 and troughed at $79.8 million in Q2 2025.
  • A 5-year average of $167.9 million and a median of $174.0 million in 2025 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: skyrocketed 65.77% in 2023 and later plummeted 59.35% in 2025.
  • Year by year, Receivables - Net stood at $159.2 million in 2022, then rose by 19.97% to $191.0 million in 2023, then fell by 19.11% to $154.5 million in 2024, then crashed by 45.5% to $84.2 million in 2025, then soared by 44.42% to $121.6 million in 2026.
  • Business Quant data shows Receivables - Net for EBS at $121.6 million in Q1 2026, $84.2 million in Q4 2025, and $149.5 million in Q3 2025.